BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferraù F, Korbonits M. Metabolic comorbidities in Cushing's syndrome. Eur J Endocrinol 2015;173:M133-57. [PMID: 26060052 DOI: 10.1530/EJE-15-0354] [Cited by in Crossref: 79] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Nishiyama M, Karashima T, Iwasaki Y, Terada Y, Fujimoto S. Unilateral adrenalectomy partially improved hyperglycemia in a patient with primary bilateral macronodular adrenal hyperplasia. Diabetol Int 2021;12:480-4. [PMID: 34567928 DOI: 10.1007/s13340-021-00503-8] [Reference Citation Analysis]
2 Torky A, Sinaii N, Jha S, Desai J, El-Maouche D, Mallappa A, Merke DP. Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2021;106:e5247-57. [PMID: 33677504 DOI: 10.1210/clinem/dgab133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Nappi F, Barrea L, Di Somma C, Savanelli MC, Muscogiuri G, Orio F, Savastano S. Endocrine Aspects of Environmental "Obesogen" Pollutants. Int J Environ Res Public Health 2016;13:E765. [PMID: 27483295 DOI: 10.3390/ijerph13080765] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
4 Kinlein SA, Shahanoor Z, Romeo RD, Karatsoreos IN. Chronic Corticosterone Treatment During Adolescence Has Significant Effects on Metabolism and Skeletal Development in Male C57BL6/N Mice. Endocrinology 2017;158:2239-54. [PMID: 28510653 DOI: 10.1210/en.2017-00208] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
5 Vega-Beyhart A, Iruarrizaga M, Pané A, García-Eguren G, Giró O, Boswell L, Aranda G, Flores V, Casals G, Alonso C, Mora M, Halperin I, Carmona F, Enseñat J, Vidal O, Hu T, Rojo G, Gomis R, Hanzu FA. Endogenous cortisol excess confers a unique lipid signature and metabolic network. J Mol Med (Berl) 2021;99:1085-99. [PMID: 33881561 DOI: 10.1007/s00109-021-02076-0] [Reference Citation Analysis]
6 Casco S, Soto-Vega E. Development of Metabolic Syndrome Associated to Cancer Therapy: Review. Horm Cancer 2016;7:289-95. [PMID: 27704369 DOI: 10.1007/s12672-016-0274-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
7 Stieg MR, Auer MK, Berr C, Fazel J, Reincke M, Zopp S, Yassouridis A, Stalla GK. Clinical score system in the treatment of Cushing's disease: failure to identify discriminative variables from the German Cushing's Registry. Pituitary 2019;22:129-36. [PMID: 30734142 DOI: 10.1007/s11102-019-00942-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Martínez-Momblán MA, Gómez C, Santos A, Porta N, Esteve J, Úbeda I, Halperin I, Campillo B, Guillaumet M, Webb SM, Resmini E. A specific nursing educational program in patients with Cushing's syndrome. Endocrine 2016;53:199-209. [PMID: 26400845 DOI: 10.1007/s12020-015-0737-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
9 Koorneef LL, Kroon J, Viho EMG, Wahl LF, Heckmans KML, van Dorst MMAR, Hoekstra M, Houtman R, Hunt H, Meijer OC. The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity. J Endocrinol 2020;246:79-92. [PMID: 32369774 DOI: 10.1530/JOE-19-0486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Sun X, Feng M, Lu L, Zhao Z, Bao X, Deng K, Yao Y, Zhu H, Wang R. Lipid Abnormalities in Patients With Cushing's Disease and Its Relationship With Impaired Glucose Metabolism. Front Endocrinol (Lausanne) 2020;11:600323. [PMID: 33633684 DOI: 10.3389/fendo.2020.600323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sieber-Ruckstuhl NS, Burla B, Spoerel S, Schmid F, Venzin C, Cazenave-Gassiot A, Bendt AK, Torta F, Wenk MR, Boretti FS. Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure. Sci Rep 2019;9:6015. [PMID: 30979907 DOI: 10.1038/s41598-019-42190-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Zielinska AE, Fletcher RS, Sherlock M, Doig CL, Lavery GG. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle. Cell Biochem Funct 2017;35:269-77. [PMID: 28749080 DOI: 10.1002/cbf.3272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Parasiliti-Caprino M, Bioletto F, Frigerio T, D'Angelo V, Ceccato F, Ferraù F, Ferrigno R, Minnetti M, Scaroni C, Cannavò S, Pivonello R, Isidori A, Broglio F, Giordano R, Spinello M, Grottoli S, Arvat E. A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score. Front Endocrinol (Lausanne) 2021;12:747549. [PMID: 34675882 DOI: 10.3389/fendo.2021.747549] [Reference Citation Analysis]
14 Nyawo TA, Dludla PV, Mazibuko-Mbeje SE, Mthembu SXH, Nyambuya TM, Nkambule BB, Gijsen HS, Strijdom H, Pheiffer C. A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at risk of heart failure. Heart Fail Rev 2021. [PMID: 34671870 DOI: 10.1007/s10741-021-10160-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Higgs JA, Quinn AP, Seely KD, Richards Z, Mortensen SP, Crandall CS, Brooks AE. Pathophysiological Link between Insulin Resistance and Adrenal Incidentalomas. IJMS 2022;23:4340. [DOI: 10.3390/ijms23084340] [Reference Citation Analysis]
16 Zhou J, Zhang M, Bai X, Cui S, Pang C, Lu L, Pang H, Guo X, Wang Y, Xing B. Demographic Characteristics, Etiology, and Comorbidities of Patients with Cushing's Syndrome: A 10-Year Retrospective Study at a Large General Hospital in China. Int J Endocrinol 2019;2019:7159696. [PMID: 30915114 DOI: 10.1155/2019/7159696] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
17 Egalini F, Parasiliti Caprino M, Gaggero G, Cappiello V, Giannelli J, Rossetto Giaccherino R, Pagano L, Giordano R. Endocrine Disorders in Autoimmune Rheumatological Diseases: A Focus on Thyroid Autoimmune Diseases and on the Effects of Chronic Glucocorticoid Treatment. Endocrines 2021;2:171-84. [DOI: 10.3390/endocrines2030018] [Reference Citation Analysis]
18 Roh HC, Tsai LTY, Shao M, Tenen D, Shen Y, Kumari M, Lyubetskaya A, Jacobs C, Dawes B, Gupta RK, Rosen ED. Warming Induces Significant Reprogramming of Beige, but Not Brown, Adipocyte Cellular Identity. Cell Metab 2018;27:1121-1137.e5. [PMID: 29657031 DOI: 10.1016/j.cmet.2018.03.005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 21.0] [Reference Citation Analysis]
19 Shen Y, Roh HC, Kumari M, Rosen ED. Adipocyte glucocorticoid receptor is important in lipolysis and insulin resistance due to exogenous steroids, but not insulin resistance caused by high fat feeding. Mol Metab 2017;6:1150-60. [PMID: 29031716 DOI: 10.1016/j.molmet.2017.06.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
20 Li Z, Zhang C, Geng C, Song Y. Metabolic profile differences in ACTH-dependent and ACTH-independent Cushing syndrome. Chronic Diseases and Translational Medicine 2021. [DOI: 10.1016/j.cdtm.2021.08.004] [Reference Citation Analysis]
21 Kaikaew K, Steenbergen J, van Dijk TH, Grefhorst A, Visser JA. Sex Difference in Corticosterone-Induced Insulin Resistance in Mice. Endocrinology 2019;160:2367-87. [PMID: 31265057 DOI: 10.1210/en.2019-00194] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
22 Sahm A, Platzer M, Koch P, Henning Y, Bens M, Groth M, Burda H, Begall S, Ting S, Goetz M, Van Daele P, Staniszewska M, Klose JM, Costa PF, Hoffmann S, Szafranski K, Dammann P. Increased longevity due to sexual activity in mole-rats is associated with transcriptional changes in the HPA stress axis. Elife 2021;10:e57843. [PMID: 33724179 DOI: 10.7554/eLife.57843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Hernández-Díazcouder A, Romero-Nava R, Carbó R, Sánchez-Lozada LG, Sánchez-Muñoz F. High Fructose Intake and Adipogenesis. Int J Mol Sci 2019;20:E2787. [PMID: 31181590 DOI: 10.3390/ijms20112787] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
24 Busceti CL, Ferese R, Bucci D, Ryskalin L, Gambardella S, Madonna M, Nicoletti F, Fornai F. Corticosterone Upregulates Gene and Protein Expression of Catecholamine Markers in Organotypic Brainstem Cultures. Int J Mol Sci 2019;20:E2901. [PMID: 31197099 DOI: 10.3390/ijms20122901] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
25 Miceli DD, Vidal PN, Batter MFC, Pignataro O, Castillo VA. Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism. Open Vet J 2018;8:193-9. [PMID: 29911024 DOI: 10.4314/ovj.v8i2.13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Kineman RD, Del Rio-Moreno M, Sarmento-Cabral A. 40 YEARS of IGF1: Understanding the tissue-specific roles of IGF1/IGF1R in regulating metabolism using the Cre/loxP system. J Mol Endocrinol 2018;61:T187-98. [PMID: 29743295 DOI: 10.1530/JME-18-0076] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
27 Begall S, Nappe R, Hohrenk L, Schmidt TC, Burda H, Sahm A, Szafranski K, Dammann P, Henning Y. Life expectancy, family constellation and stress in giant mole-rats (Fukomys mechowii). Philos Trans R Soc Lond B Biol Sci 2021;376:20200207. [PMID: 33678029 DOI: 10.1098/rstb.2020.0207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Ahmed SF, Ali RHG, Fattah FH, Mahmood AG, Salih RQ, Salih AM, Tahir SH, Kakamad FH. Simultaneous pituitary and adrenal adenomas in a patient with non ACTH dependent Cushing syndrome; a case report with literature review. International Journal of Surgery Case Reports 2022. [DOI: 10.1016/j.ijscr.2022.107038] [Reference Citation Analysis]
29 Di Dalmazi G, Quinkler M, Deutschbein T, Prehn C, Rayes N, Kroiss M, Berr CM, Stalla G, Fassnacht M, Adamski J, Reincke M, Beuschlein F. Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing's syndrome. Eur J Endocrinol 2017;177:227-37. [PMID: 28566446 DOI: 10.1530/EJE-17-0109] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
30 Novaes Soares P, Silva Tavares Rodrigues V, Cherem Peixoto T, Calvino C, Aparecida Miranda R, Pereira Lopes B, Peixoto-Silva N, Lopes Costa L, Claudio-Neto S, Christian Manhães A, Oliveira E, Gaspar de Moura E, Cristina Lisboa P. Cigarette Smoke During Breastfeeding in Rats Changes Glucocorticoid and Vitamin D Status in Obese Adult Offspring. Int J Mol Sci 2018;19:E3084. [PMID: 30304827 DOI: 10.3390/ijms19103084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Schutten JC, Joris PJ, Minović I, Post A, van Beek AP, de Borst MH, Mensink RP, Bakker SJL. Long-term magnesium supplementation improves glucocorticoid metabolism: A post-hoc analysis of an intervention trial. Clin Endocrinol (Oxf) 2021;94:150-7. [PMID: 33030273 DOI: 10.1111/cen.14350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Rochette C, Castinetti F, Brue T. [Acromegaly and Cushing's disease: Persistence of comorbidities after the control of hypersecretion]. Ann Endocrinol (Paris) 2016;77 Suppl 1:S19-28. [PMID: 28645354 DOI: 10.1016/S0003-4266(17)30074-4] [Reference Citation Analysis]
33 Gatto F, Florio T. Does pasireotide directly modulate skeletal muscle metabolism? Endocrine 2017;57:6-8. [PMID: 28386722 DOI: 10.1007/s12020-017-1291-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Ragucci E, Nguyen D, Lamerson M, Moraitis AG. Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma. Case Rep Endocrinol 2017;2017:6161348. [PMID: 29348947 DOI: 10.1155/2017/6161348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
35 Elaković I, Kovačević S, Vojnović Milutinović D, Nikolić-Kokić A, Glban AM, Spasić M, Tappy L, Djordjevic A, Matić G, Brkljačić J. Fructose Consumption Affects Glucocorticoid Signaling in the Liver of Young Female Rats. Nutrients 2020;12:E3470. [PMID: 33198224 DOI: 10.3390/nu12113470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Gasparini SJ, Swarbrick MM, Kim S, Thai LJ, Henneicke H, Cavanagh LL, Tu J, Weber MC, Zhou H, Seibel MJ. Androgens sensitise mice to glucocorticoid-induced insulin resistance and fat accumulation. Diabetologia 2019;62:1463-77. [PMID: 31098671 DOI: 10.1007/s00125-019-4887-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
37 Kim JH, Kwak MK, Ahn SH, Kim H, Cho YY, Suh S, Kim BJ, Song KH, Lee SH, Koh JM. Alteration in skeletal muscle mass in women with subclinical hypercortisolism. Endocrine 2018;61:134-43. [PMID: 29717464 DOI: 10.1007/s12020-018-1598-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
38 Brue T, Castinetti F. The risks of overlooking the diagnosis of secreting pituitary adenomas. Orphanet J Rare Dis 2016;11:135. [PMID: 27716353 DOI: 10.1186/s13023-016-0516-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
39 Nankova AB, Yaneva M, Elenkova A, Kalinov K, Zacharieva S. ARE THERE RELIABLE PREDICTORS FOR THE IMPAIRED QUALITY OF LIFE IN PATIENTS WITH CUSHING'S SYNDROME? Acta Endocrinol (Buchar) 2019;15:482-90. [PMID: 32377246 DOI: 10.4183/aeb.2019.482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Albani A, Ferraù F, Ciresi A, Pivonello R, Scaroni C, Iacuaniello D, Zilio M, Guarnotta V, Alibrandi A, Messina E, Boscaro M, Giordano C, Colao A, Cannavo S. Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study. Endocrine 2018;61:118-24. [PMID: 29383677 DOI: 10.1007/s12020-018-1524-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
41 Sabbadin C, Armanini D. Syndromes that Mimic an Excess of Mineralocorticoids. High Blood Press Cardiovasc Prev 2016;23:231-5. [PMID: 27251484 DOI: 10.1007/s40292-016-0160-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
42 Vogel F, Reincke M. Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess. Rev Endocr Metab Disord 2021. [PMID: 34241765 DOI: 10.1007/s11154-021-09670-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Schernthaner-Reiter MH, Wolf P, Vila G, Luger A. The Interaction of Insulin and Pituitary Hormone Syndromes. Front Endocrinol (Lausanne) 2021;12:626427. [PMID: 33995272 DOI: 10.3389/fendo.2021.626427] [Reference Citation Analysis]
44 Ferriere A, Tabarin A. Cushing's disease. Presse Med 2021;50:104091. [PMID: 34718112 DOI: 10.1016/j.lpm.2021.104091] [Reference Citation Analysis]
45 Glantschnig C, Mattijssen F, Vogl ES, Ali Khan A, Rios Garcia M, Fischer K, Müller T, Uhlenhaut H, Nawroth P, Scheideler M, Rose AJ, Pellegata N, Herzig S. The glucocorticoid receptor in brown adipocytes is dispensable for control of energy homeostasis. EMBO Rep 2019;20:e48552. [PMID: 31559673 DOI: 10.15252/embr.201948552] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
46 Sevilla LM, Bigas J, Chiner-Oms Á, Comas I, Sentandreu V, Pérez P. Glucocorticoid-dependent transcription in skin requires epidermal expression of the glucocorticoid receptor and is modulated by the mineralocorticoid receptor. Sci Rep 2020;10:18954. [PMID: 33144612 DOI: 10.1038/s41598-020-75853-5] [Reference Citation Analysis]
47 Yates W, Mccluskey P, Wakefield D. Long-term immunosuppressive therapy for inflammatory eye disease – the link between systemic treatment, cardiovascular risk and disease? Expert Review of Ophthalmology 2017;12:321-30. [DOI: 10.1080/17469899.2017.1349610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Pappachan JM, Hariman C, Edavalath M, Waldron J, Hanna FW. Cushing's syndrome: a practical approach to diagnosis and differential diagnoses. J Clin Pathol 2017;70:350-9. [PMID: 28069628 DOI: 10.1136/jclinpath-2016-203933] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
49 Oh J, Lee D, Yun T, Koo Y, Chae Y, Yang M, Kang B, Kim H. Inverse relationship between eosinophil profiles and serum glucose concentration in dogs with naturally occurring hypercortisolism. Domestic Animal Endocrinology 2022. [DOI: 10.1016/j.domaniend.2022.106727] [Reference Citation Analysis]
50 Fleseriu M, Petersenn S, Biller BMK, Kadioglu P, De Block C, T'Sjoen G, Vantyghem MC, Tauchmanova L, Wojna J, Roughton M, Lacroix A, Newell-Price J. Long-term efficacy and safety of once-monthly pasireotide in Cushing's disease: A Phase III extension study. Clin Endocrinol (Oxf) 2019;91:776-85. [PMID: 31465533 DOI: 10.1111/cen.14081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
51 Aranda G, Lopez C, Fernandez-Ruiz R, Esteban Y, Garcia-Eguren G, Mora M, Halperin I, Casals G, Enseñat J, Hanzu FA. Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers. Int J Endocrinol 2017;2017:2912763. [PMID: 29213284 DOI: 10.1155/2017/2912763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]